Literature DB >> 25901521

MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1.

Ji-Yong Sun1, Wei-Zhong Xiao2, Fei Wang3, Yong-Qian Wang4, You-Hou Zhu3, Yi-Fang Wu3, Zeng-Li Miao1, Yu-Chang Lin1.   

Abstract

MicroRNAs (miRs) are a class of small non-coding RNAs that are involved in the regulation of gene expression, and in cancer development and progression. In the present study, miR-320 expression was found to be significantly reduced in glioma tissue in comparison with that in adjacent healthy tissues. In the present study, in vitro analyses demonstrated that overexpression of miR-320 inhibited cell proliferation and metastasis, while antisense miR-320 oligonucleotides enhanced cell proliferation and migration in U251 and SHG-44 glioma cell lines, compared with that in negative control cells. Protein expression of E2F1, a cell-cycle regulator, was negatively regulated by miR-320. Therefore, the present study provides novel insights into the association between miR-320 and glioma development.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25901521     DOI: 10.3892/mmr.2015.3657

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  20 in total

1.  MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1.

Authors:  Can Shi; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2017-07-21       Impact factor: 2.967

Review 2.  MicroRNA and extracellular vesicles in glioblastoma: small but powerful.

Authors:  Arun K Rooj; Marco Mineo; Jakub Godlewski
Journal:  Brain Tumor Pathol       Date:  2016-03-11       Impact factor: 3.298

Review 3.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

4.  ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation.

Authors:  Guiyan Xu; Jian Yi Li
Journal:  J Neurooncol       Date:  2015-11-02       Impact factor: 4.130

Review 5.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

6.  Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.

Authors:  Zanxi Fang; Jing Tang; Yongying Bai; Huayue Lin; Hanyu You; Hongwei Jin; Lingqing Lin; Pan You; Juan Li; Zhang Dai; Xianming Liang; Yuanhui Su; Qing Hu; Fen Wang; Zhong-Ying Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-08-22

7.  Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.

Authors:  Srinivasulu Yerukala Sathipati; Hui-Ling Huang; Shinn-Ying Ho
Journal:  BMC Genomics       Date:  2016-12-22       Impact factor: 3.969

Review 8.  MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.

Authors:  Huda Alfardus; Alan McIntyre; Stuart Smith
Journal:  Biomed Res Int       Date:  2017-07-19       Impact factor: 3.411

Review 9.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

10.  MicroRNA-320 Enhances Radiosensitivity of Glioma Through Down-Regulation of Sirtuin Type 1 by Directly Targeting Forkhead Box Protein M1.

Authors:  Tengfei Li; Ji Ma; Xinwei Han; Yongxu Jia; Huifeng Yuan; Shaofeng Shui; Dong Guo
Journal:  Transl Oncol       Date:  2018-01-11       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.